Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Risperidone Patent Expiration

Risperidone is used for treating various conditions such as depression, anxiety, and obsessive-compulsive disorder. It was first introduced by Janssen Pharmaceuticals Inc in its drug Risperdal on Dec 29, 1993. Other drugs containing Risperidone are Rykindo, Risperdal Consta, Perseris Kit, Uzedy, Risvan. 44 different companies have introduced drugs containing Risperidone.


Risperidone Patents

Given below is the list of patents protecting Risperidone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Uzedy US9023897 Biodegradable drug delivery compositions Apr 05, 2033 Teva
Rykindo US10098882 Risperidone sustained release microsphere composition Apr 10, 2032 Shandong Luye
Rykindo US10406161 Risperidone sustained release microsphere composition Apr 10, 2032 Shandong Luye
Rykindo US11110094 Risperidone sustained release microsphere composition Apr 10, 2032 Shandong Luye
Rykindo US9446135 Risperidone sustained release microsphere composition Apr 10, 2032 Shandong Luye
Rykindo US9532991 Risperidone sustained release microsphere composition Apr 10, 2032 Shandong Luye
Risvan US10058504 Methods for the preparation of injectable depot compositions May 31, 2031 Labs Farms Rovi Sa
Risvan US10085936 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Risvan US10182982 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Risvan US10195138 Methods for the preparation of injectable depot compositions May 31, 2031 Labs Farms Rovi Sa
Risvan US10335366 Risperidone or paliperidone implant formulation May 31, 2031 Labs Farms Rovi Sa
Risvan US10463607 Antipsychotic Injectable Depot Composition May 31, 2031 Labs Farms Rovi Sa
Risvan US10881605 Methods for the preparation of injectable depot compositions May 31, 2031 Labs Farms Rovi Sa
Risvan US11007139 Risperidone or paliperidone implant formulation May 31, 2031 Labs Farms Rovi Sa
Risvan US11173110 Risperidone or paliperidone implant formulation May 31, 2031 Labs Farms Rovi Sa
Risvan US11241377 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Risvan US11752092 Methods for the preparation of injectable depot compositions May 31, 2031 Labs Farms Rovi Sa
Risvan US11752093 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Risvan US11752094 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Risvan US11759416 Antipsychotic injectable depot composition May 31, 2031 Labs Farms Rovi Sa
Perseris Kit US10010612 Sustained delivery formulations of risperidone compounds Feb 13, 2028 Indivior
Perseris Kit US10376590 Sustained delivery formulations of risperidone compound Feb 13, 2028 Indivior
Perseris Kit US11013809 Sustained delivery formulations of risperidone compound Feb 13, 2028 Indivior
Perseris Kit US11712475 Sustained delivery formulations of risperidone compound Feb 13, 2028 Indivior
Perseris Kit US9180197 Sustained delivery formulations of risperidone compounds Feb 13, 2028 Indivior
Perseris Kit US9186413 Sustained delivery formulations of risperidone compounds Feb 13, 2028 Indivior
Uzedy US8221778 Drug-containing implants and methods of use thereof Nov 12, 2027 Teva
Uzedy US8741327 Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant Nov 12, 2027 Teva
Perseris Kit US11110093 Sustained release small molecule drug formulation Nov 05, 2026 Indivior
Perseris Kit US10058554 Sustained release small molecule drug formulation Sep 26, 2026 Indivior
Perseris Kit US9597402 Sustained release small molecule drug formulation Sep 26, 2026 Indivior
Perseris Kit US10406160 Sustained release small molecule drug formulation Jun 26, 2026 Indivior
Uzedy US10736965 Risperidone biodegradable implant Jan 12, 2025 Teva
Uzedy US8802127 Risperidone-containing PLA:PGA implants and methods of use thereof Jan 12, 2025 Teva
Uzedy US9439905 Risperidone-containing implants and methods of use thereof Jan 12, 2025 Teva
Uzedy US9717799 Drug-containing implants and methods of use thereof Jan 12, 2025 Teva
Uzedy US9895447 Drug-containing PLA implants and methods of use thereof Jan 12, 2025 Teva
Uzedy US9925268 Drug-containing implants and methods of use thereof Jan 12, 2025 Teva
Risperdal Consta US6667061

(Pediatric)

 Preparation of injectable suspensions having improved injectability Nov 25, 2020

(Expired)

 Janssen Pharms
Risperdal Consta US6667061 Preparation of injectable suspensions having improved injectability May 25, 2020

(Expired)

 Janssen Pharms
Risperdal Consta US6194006

(Pediatric)

 Preparation of microparticles having a selected release profile Jun 30, 2019

(Expired)

 Janssen Pharms
Risperdal Consta US6379703

(Pediatric)

 Preparation of microparticles having a selected release profile Jun 30, 2019

(Expired)

 Janssen Pharms
Risperdal Consta US6596316

(Pediatric)

 Preparation of microparticles having a selected release profile Jun 30, 2019

(Expired)

 Janssen Pharms
Risperdal Consta US6194006 Preparation of microparticles having a selected release profile Dec 30, 2018

(Expired)

 Janssen Pharms
Risperdal Consta US6379703 Preparation of microparticles having a selected release profile Dec 30, 2018

(Expired)

 Janssen Pharms
Risperdal Consta US6596316 Preparation of microparticles having a selected release profile Dec 30, 2018

(Expired)

 Janssen Pharms
Risperdal US6224905

(Pediatric)

 Biconvex rapidly disintegrating dosage forms Dec 10, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US5792477

(Pediatric)

 Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent Nov 02, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US5916598

(Pediatric)

 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent Nov 02, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US6403114

(Pediatric)

 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent Nov 02, 2017

(Expired)

 Janssen Pharms
Risperdal US6224905 Biconvex rapidly disintegrating dosage forms Jun 10, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US5792477 Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent May 02, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US5916598 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent May 02, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US6403114 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent May 02, 2017

(Expired)

 Janssen Pharms
Risperdal Consta US5688801

(Pediatric)

 Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles May 18, 2015

(Expired)

 Janssen Pharms
Risperdal US5648093

(Pediatric)

 Pharmaceutical and other dosage forms Jan 15, 2015

(Expired)

 Janssen Pharms
Risperdal US5453425

(Pediatric)

 Risperidone oral formulation Jan 11, 2015

(Expired)

 Janssen Pharms
Risperdal USRE39181

(Pediatric)

 Aqueous risperidone formulations Jan 11, 2015

(Expired)

 Janssen Pharms
Risperdal Consta US5688801 Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Nov 18, 2014

(Expired)

 Janssen Pharms
Risperdal US5648093 Pharmaceutical and other dosage forms Jul 15, 2014

(Expired)

 Janssen Pharms
Risperdal US5453425 Risperidone oral formulation Jul 11, 2014

(Expired)

 Janssen Pharms
Risperdal USRE39181 Aqueous risperidone formulations Jul 11, 2014

(Expired)

 Janssen Pharms
Risperdal Consta US5965168

(Pediatric)

 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles May 19, 2014

(Expired)

 Janssen Pharms
Risperdal Consta US6110921

(Pediatric)

 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles May 19, 2014

(Expired)

 Janssen Pharms
Risperdal Consta US6368632

(Pediatric)

 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles May 19, 2014

(Expired)

 Janssen Pharms
Risperdal Consta US7547452

(Pediatric)

 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles May 19, 2014

(Expired)

 Janssen Pharms
Risperdal Consta US5965168 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Nov 19, 2013

(Expired)

 Janssen Pharms
Risperdal Consta US6110921 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Nov 19, 2013

(Expired)

 Janssen Pharms
Risperdal Consta US6368632 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Nov 19, 2013

(Expired)

 Janssen Pharms
Risperdal Consta US7547452 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Nov 19, 2013

(Expired)

 Janssen Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Risperidone's patents.

Given below is the list recent legal activities going on the following patents of Risperidone.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 03 Jul, 2024 US9532991
Surcharge for Late Payment, Large Entity 17 Apr, 2024 US10736965
Payment of Maintenance Fee, 4th Year, Large Entity 17 Apr, 2024 US10736965
Maintenance Fee Reminder Mailed
Critical
 01 Apr, 2024 US10736965
Payment of Maintenance Fee, 8th Year, Large Entity 19 Mar, 2024 US9446135
Payment of Maintenance Fee, 8th Year, Large Entity 28 Feb, 2024 US9439905
Payment of Maintenance Fee, 12th Yr, Small Entity 03 Jan, 2024 US8221778
Payment of Maintenance Fee, 4th Year, Large Entity 10 Mar, 2023 US10406161
Payment of Maintenance Fee, 8th Year, Large Entity 02 Nov, 2022 US9023897
Payment of Maintenance Fee, 4th Year, Large Entity 28 Mar, 2022 US10098882


Risperidone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Risperidone Generic API Manufacturers

Several generic applications have been filed for Risperidone. The first generic version for Risperidone was by Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc and was approved on Jun 30, 2008. And the latest generic version is by Ipca Laboratories Ltd and was approved on Jun 26, 2024.

Given below is the list of companies who have filed for Risperidone generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 5 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet, orally disintegrating Discontinued ORAL N/A Apr 19, 2011
0.5MG

tablet, orally disintegrating Discontinued ORAL N/A Apr 19, 2011
1MG

tablet, orally disintegrating Discontinued ORAL N/A Apr 19, 2011
3MG

tablet, orally disintegrating Discontinued ORAL N/A Apr 19, 2011
2MG

tablet, orally disintegrating Discontinued ORAL N/A Apr 19, 2011





2. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AB Aug 24, 2011
3MG

tablet Prescription ORAL AB Aug 24, 2011
0.5MG

tablet Prescription ORAL AB Aug 24, 2011
1MG

tablet Prescription ORAL AB Aug 24, 2011
4MG

tablet Prescription ORAL AB Aug 24, 2011
0.25MG

tablet Prescription ORAL AB Aug 24, 2011


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





3. AMNEAL

Amneal Pharmaceuticals Llc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AB Jun 17, 2009
4MG

tablet Prescription ORAL AB Jun 17, 2009
3MG

tablet Prescription ORAL AB Jun 17, 2009
2MG

tablet Prescription ORAL AB Jun 17, 2009
0.25MG

tablet Prescription ORAL AB Jun 17, 2009
0.5MG

tablet Prescription ORAL AB Jun 17, 2009


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Piscataway Amneal Pharmaceuticals, LLC
Branchburg Amneal Pharmaceuticals, LLC
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Hyderabad Amneal Oncology Private Limited





4. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Prescription ORAL AA May 25, 2011





5. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Jan 30, 2009





6. APOTEX INC

Apotex Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet Prescription ORAL AB Sep 15, 2008
3MG

tablet Prescription ORAL AB Sep 15, 2008
2MG

tablet Prescription ORAL AB Sep 15, 2008
1MG

tablet Prescription ORAL AB Sep 15, 2008
0.5MG

tablet Prescription ORAL AB Sep 15, 2008
0.25MG

tablet Prescription ORAL AB Sep 15, 2008


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.





7. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Prescription ORAL AA Sep 4, 2009


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





8. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 7 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet Prescription ORAL AB May 18, 2011
4MG

tablet Prescription ORAL AB May 18, 2011
3MG

tablet Prescription ORAL AB May 18, 2011
2MG

tablet Prescription ORAL AB May 18, 2011
0.5MG

tablet Prescription ORAL AB May 18, 2011
0.25MG

tablet Prescription ORAL AB May 18, 2011
1MG/ML

solution Prescription ORAL AA Jan 12, 2015





9. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 12, 2012
1MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 12, 2012
2MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 12, 2012





10. DASH PHARMS

Dash Pharmaceuticals Llc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Dash Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet, orally disintegrating Discontinued ORAL N/A Feb 12, 2013
0.5MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 30, 2011
1MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 30, 2011
2MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 30, 2011
3MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 30, 2011
4MG

tablet, orally disintegrating Discontinued ORAL N/A Mar 30, 2011





11. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

tablet, orally disintegrating Prescription ORAL AB Oct 5, 2009
4MG

tablet, orally disintegrating Prescription ORAL AB Nov 30, 2009
2MG

tablet, orally disintegrating Prescription ORAL AB Feb 24, 2009
0.25MG

tablet Prescription ORAL AB Oct 24, 2008
0.5MG

tablet, orally disintegrating Prescription ORAL AB Feb 24, 2009
3MG

tablet, orally disintegrating Prescription ORAL AB Nov 30, 2009





12. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet, orally disintegrating Prescription ORAL N/A Apr 30, 2009
0.5MG

tablet, orally disintegrating Prescription ORAL AB Apr 30, 2009
2MG

tablet, orally disintegrating Prescription ORAL AB Apr 30, 2009
3MG

tablet, orally disintegrating Prescription ORAL AB Apr 30, 2009
4MG

tablet, orally disintegrating Prescription ORAL AB Apr 30, 2009
1MG

tablet, orally disintegrating Prescription ORAL AB Oct 26, 2009





13. ESJAY PHARMA

Esjay Pharma Llc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Esjay Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL AB Oct 9, 2008
3MG

tablet Prescription ORAL AB Oct 9, 2008
0.25MG

tablet Prescription ORAL AB Oct 9, 2008
2MG

tablet Prescription ORAL AB Oct 9, 2008
1MG

tablet Prescription ORAL AB Oct 9, 2008
4MG

tablet Prescription ORAL AB Oct 9, 2008





14. HERITAGE PHARMA AVET

Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet Discontinued ORAL N/A Oct 16, 2008
0.5MG

tablet Discontinued ORAL N/A Oct 16, 2008
1MG

tablet Discontinued ORAL N/A Oct 16, 2008
2MG

tablet Discontinued ORAL N/A Oct 16, 2008
3MG

tablet Discontinued ORAL N/A Oct 16, 2008
4MG

tablet Discontinued ORAL N/A Oct 16, 2008





15. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Jul 29, 2009


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





16. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet Prescription ORAL AB Jun 26, 2024
3MG

tablet Prescription ORAL AB Jun 26, 2024
2MG

tablet Prescription ORAL AB Jun 26, 2024
1MG

tablet Prescription ORAL AB Jun 26, 2024
0.5MG

tablet Prescription ORAL AB Jun 26, 2024
0.25MG

tablet Prescription ORAL AB Jun 26, 2024





17. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet Discontinued ORAL N/A Mar 23, 2009
0.25MG

tablet Discontinued ORAL N/A Mar 23, 2009
0.5MG

tablet Discontinued ORAL N/A Mar 23, 2009
1MG

tablet Discontinued ORAL N/A Mar 23, 2009
2MG

tablet Discontinued ORAL N/A Mar 23, 2009
3MG

tablet Discontinued ORAL N/A Mar 23, 2009


Manufacturing Plant Locations
New

Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.

Country City Firm Name
United States
Salisbury Jubilant Cadista Pharmaceuticals, Inc.





18. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 5 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet, orally disintegrating Prescription ORAL AB Nov 4, 2011
2MG

tablet, orally disintegrating Prescription ORAL AB Nov 4, 2011
4MG

tablet, orally disintegrating Prescription ORAL AB Nov 4, 2011
1MG

(reference standard)

tablet, orally disintegrating Prescription ORAL AB Nov 4, 2011
3MG

tablet, orally disintegrating Prescription ORAL AB Nov 4, 2011


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





19. LANNETT CO INC

Lannett Co Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Prescription ORAL AA Dec 3, 2010





20. PHARM ASSOC

Pharmaceutical Associates Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Pharm Assoc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Jul 29, 2009





21. PRECISION DOSE

Precision Dose Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Precision Dose.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Jun 28, 2010


Manufacturing Plant Locations
New

Precision Dose's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Precision Dose as present at those locations.

Country City Firm Name
United States
South Beloit Precision Dose Inc.





22. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL AB Nov 29, 2011
4MG

tablet Prescription ORAL AB Nov 29, 2011
3MG

tablet Prescription ORAL AB Nov 29, 2011
2MG

tablet Prescription ORAL AB Nov 29, 2011
1MG

tablet Prescription ORAL AB Nov 29, 2011
0.25MG

tablet Prescription ORAL AB Nov 29, 2011





23. RATIOPHARM

Ratiopharm has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Ratiopharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Discontinued ORAL N/A Jun 8, 2010
3MG

tablet Discontinued ORAL N/A Jun 8, 2010
1MG

tablet Discontinued ORAL N/A Jun 8, 2010
0.5MG

tablet Discontinued ORAL N/A Jun 8, 2010
0.25MG

tablet Discontinued ORAL N/A Jun 8, 2010
4MG

tablet Discontinued ORAL N/A Jun 8, 2010


Manufacturing Plant Locations
New

Ratiopharm's manufacturing plants are situated in 1 country - Germany. Given below are the details of these plant locations as well as the firm names of Ratiopharm as present at those locations.

Country City Firm Name
Germany
Ulm Ratiopharm GmbH





24. RENATA

Renata Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Renata.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet Prescription ORAL AB Dec 29, 2008
2MG

tablet Prescription ORAL AB Dec 29, 2008
3MG

tablet Prescription ORAL AB Dec 29, 2008
0.5MG

tablet Prescription ORAL AB Dec 29, 2008
0.25MG

tablet Prescription ORAL AB Dec 29, 2008
1MG

tablet Prescription ORAL AB Dec 29, 2008


Manufacturing Plant Locations
New

Renata's manufacturing plants are situated in 5 countries - Brazil, United States, Hungary, Bangladesh, Poland. Given below are the details of these plant locations as well as the firm names of Renata as present at those locations.

Country City Firm Name
Brazil
Rio De Janeiro Renata de Souza Cravo
United States
San Francisco Renata Gallagher, M.D.
Hungary
Miskolc Renata Kun, M.D.
Bangladesh
Gazipur Renata Limited (General Plant 2)
Poland
Warsaw Renata Sienkiewicz-Kozlowska, MD





25. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL AB Oct 8, 2008
4MG

tablet Prescription ORAL AB Oct 8, 2008
3MG

tablet Prescription ORAL AB Oct 8, 2008
2MG

tablet Prescription ORAL AB Oct 8, 2008
1MG

tablet Prescription ORAL AB Oct 8, 2008
0.25MG

tablet Prescription ORAL AB Oct 8, 2008


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





26. SANDOZ

Sandoz Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet, orally disintegrating Prescription ORAL AB Dec 22, 2009
1MG

tablet, orally disintegrating Prescription ORAL AB Dec 22, 2009
0.5MG

tablet, orally disintegrating Prescription ORAL AB Dec 22, 2009
0.25MG

tablet Prescription ORAL AB Oct 16, 2009
4MG

tablet, orally disintegrating Prescription ORAL AB Dec 22, 2009
3MG

tablet, orally disintegrating Prescription ORAL AB Dec 22, 2009


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





27. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Jul 29, 2009





28. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet Discontinued ORAL N/A Mar 10, 2014
1MG

tablet Discontinued ORAL N/A Mar 10, 2014
4MG

tablet Discontinued ORAL N/A Mar 10, 2014
3MG

tablet Discontinued ORAL N/A Mar 10, 2014
2MG

tablet Discontinued ORAL N/A Mar 10, 2014
0.5MG

tablet Discontinued ORAL N/A Mar 10, 2014





29. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3MG

tablet, orally disintegrating Prescription ORAL AB Apr 8, 2013
4MG

tablet, orally disintegrating Prescription ORAL AB Apr 8, 2013
1MG

tablet, orally disintegrating Prescription ORAL AB Apr 8, 2013
0.5MG

tablet, orally disintegrating Prescription ORAL AB Apr 8, 2013
2MG

tablet, orally disintegrating Prescription ORAL AB Apr 8, 2013





30. SYNTHON PHARMS

Synthon Pharmaceuticals Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Synthon Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Discontinued ORAL N/A Oct 22, 2009
3MG

tablet Discontinued ORAL N/A Oct 22, 2009
4MG

tablet Discontinued ORAL N/A Oct 22, 2009
0.25MG

tablet Discontinued ORAL N/A Oct 22, 2009
0.5MG

tablet Discontinued ORAL N/A Oct 22, 2009
1MG

tablet Discontinued ORAL N/A Oct 22, 2009





31. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Prescription ORAL AA Feb 7, 2011


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Honolulu Taro Delight, LLC
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





32. TEVA PHARMS USA INC

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG/VIAL

injectable Prescription INTRAMUSCULAR AB Dec 5, 2023
25MG/VIAL

injectable Prescription INTRAMUSCULAR AB Dec 5, 2023
37.5MG/VIAL

injectable Prescription INTRAMUSCULAR AB Dec 5, 2023
50MG/VIAL

injectable Prescription INTRAMUSCULAR AB Dec 5, 2023





33. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL AB Oct 30, 2008
4MG

tablet Prescription ORAL AB Oct 30, 2008
3MG

tablet Prescription ORAL AB Oct 30, 2008
2MG

tablet Prescription ORAL AB Oct 30, 2008
1MG

tablet Prescription ORAL AB Oct 30, 2008
0.25MG

tablet Prescription ORAL AB Oct 30, 2008





34. TRIS PHARMA INC

Tris Pharma Inc has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Tris Pharma Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Prescription ORAL AA Dec 12, 2012


Manufacturing Plant Locations
New

Tris Pharma Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Tris Pharma Inc as present at those locations.

Country City Firm Name
United States
Monmouth Junction Tris Pharma Inc.





35. WATSON LABS

Watson Laboratories Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Discontinued ORAL N/A Dec 5, 2008
1MG

tablet Discontinued ORAL N/A Dec 5, 2008
2MG

tablet Discontinued ORAL N/A Dec 5, 2008
3MG

tablet Discontinued ORAL N/A Dec 5, 2008
4MG

tablet Discontinued ORAL N/A Dec 5, 2008
0.25MG

tablet Discontinued ORAL N/A Dec 5, 2008





36. WEST WARD PHARMS

West Ward Pharmaceuticals Corp has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by West Ward Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Discontinued ORAL N/A May 29, 2009
1MG

tablet Discontinued ORAL N/A May 29, 2009
2MG

tablet Discontinued ORAL N/A May 29, 2009
3MG

tablet Discontinued ORAL N/A May 29, 2009
4MG

tablet Discontinued ORAL N/A May 29, 2009
0.25MG

tablet Discontinued ORAL N/A May 29, 2009





37. WOCKHARDT

Wockhardt Ltd has filed for 1 generic for Risperidone. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG/ML

solution Discontinued ORAL N/A Oct 8, 2009


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Aurangabad Wockhardt Limited
Solan, Nalagarh Wockhardt Limited - Baddi
Ankleshwar Wockhardt, Ltd.





38. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet, orally disintegrating Prescription ORAL AB May 1, 2009
0.5MG

tablet, orally disintegrating Prescription ORAL AB May 1, 2009





39. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Risperidone. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3MG

tablet Prescription ORAL AB Oct 16, 2008
4MG

tablet Prescription ORAL AB Oct 16, 2008
0.25MG

tablet Prescription ORAL AB Oct 16, 2008
0.5MG

tablet Prescription ORAL AB Oct 16, 2008
1MG

tablet Prescription ORAL AB Oct 16, 2008
2MG

tablet Prescription ORAL AB Oct 16, 2008